K. De Boeck

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “The Effect of Synonymous Single-Nucleotide Polymorphisms on an Atypical Cystic Fibrosis Clinical Presentation”.

The Effect of Synonymous Single-Nucleotide Polymorphisms on an Atypical Cystic Fibrosis Clinical Presentation

Life(2020)10.3390/life11010014

N/A

0DataRank · unranked

10 citations

Anabela S. Ramalho, Leonardo Santos, Johannes Wagner, Lieven Dupont, Harry Cuppens +3 more

Building global development strategies for cf therapeutics during a transitional cftr modulator era

Journal of Cystic Fibrosis(2020)10.1016/j.jcf.2020.05.011

N/A

0DataRank · unranked

31 citations

Silke van Koningsbruggen‐Rietschel, David P. Nichols, Donald R. VanDevanter, Jane C. Davies, T. Lee +20 more

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation

UNC Libraries(2020)10.17615/fm1q-nk97

N/A

0DataRank · unranked

31 citations

Michael W. Konstan, Steven M. Rowe, Manfred Ballmann, Laurent Vernillet, Jordan Dunitz +25 more

Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00324-7

N/A

0DataRank · unranked

55 citations

Susan E. Birket, John P. Clancy, D.G. Downey, John F. Engelhardt, Isabelle Fajac +8 more